一种基于原则的方法来调整监督治疗的未测量的时间稳定混
Jeppe Ekstrand Halkjær Madsen1,2, Thomas Delvin1, Thomas Scheike2
1Global Clinical Development, Leo Pharma A/S, Ballerup, Denmark.
Biometrical journal. Biometrische Zeitschrift
|December 17, 2024
概括
这项研究引入了一种新方法,用于控制固定间隔的治疗研究中未测量的混. 这种方法有效地确定了抗抑郁药对药物中毒的保护作用.
科学领域:
- 流行病学 流行病学
- 生物统计学 生物统计学
- 药物监督 药物监督 药物监督
背景情况:
- 在观察性研究中,未测量的时间稳定混是一个重大挑战.
- 根据指示进行混可能会导致结果偏差,特别是在精神病药物研究中.
- 固定的治疗间隔为混调整提供了独特的机会.
研究的目的:
- 提出一种新的统计方法来调整未测量的时间稳定混.
- 在治疗的潜在时间内解决权利审查问题.
- 调查抑郁症/焦虑症药物对后续药物中毒的影响.
主要方法:
- 专注于一个新用户队列,固定治疗给药间隔.
- 调整潜在的治疗时间以消除混.
- 使用预期最大化算法来处理正确的审查.
- 将该方法应用于丹麦国家注册数据.
主要成果:
- 提出的方法成功地调整了未测量的时间稳定混.
- 选择性血清素再吸收抑制剂 (SSRI) 显示出对药物中毒 (1年风险差异) 的保护作用.
- 标准考克斯模型分析表明了有害影响,突出了因指示而混的影响.
结论:
- 这种新方法有效地消除了固定间隔处理设置中未测量的时间稳定混.
- 这些发现表明SSRI在药物中毒方面起着保护作用,这与标准分析相反.
- 这种方法在药理流行病学中为因果推理提供了一个强大的方法.
相关概念视频
Strategies for Assessing and Addressing Confounding
83
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
83
Comparing the Survival Analysis of Two or More Groups
149
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
149
Confounding in Epidemiological Studies
143
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
143
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Kaplan-Meier Approach
94
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
94


